<DOC>
	<DOCNO>NCT00577746</DOCNO>
	<brief_summary>The goal prospective study determine clinical economic impact endoscopic ultrasound ( EUS ) stag NSCLC . Aims : 1 ) Determine accuracy EUS stag NSCLC 2 ) Measure 5-year survival 3 ) Measure quality life patient undergo surgery 4 ) Determine cost benefit EUS stag NSCLC .</brief_summary>
	<brief_title>Clinical Impact EUS Staging NSCLC</brief_title>
	<detailed_description />
	<criteria>Any subject presume know potentially resectable NSCLC Due nature NSCLC , child ( &lt; 18 year age ) consider Men , woman , minority Subjects must able safely undergo conscious sedation EUS procedure Subjects must surgical candidate Subjects must uncorrectable coagulopathy must able refrain use aspirin one week prior EUS Patient must provide sign write informed consent Subjects history previously treat lung , head &amp; neck , esophageal cancer eligible histologic cell type determine biopsied EUSFNA Uncorrectable coagulopathy Significant comorbidities uncontrolled heart failure , severe chronic obstructive pulmonary disease ( COPD ) would limit survivability surgery Evidence significant active infection ( e.g . pneumonia , peritonitis , wound abscess ) Evidence serious ongoing illness uncontrolled metabolic disease ( diabetes mellitus , hypothyroidism , etc . ) cardiac condition Evidence dementia alter mental status would prohibit give understand informed consent , evidence psychiatric illness would preclude adequate compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Non Small Cell Lung</keyword>
</DOC>